Phoenix Molecular Designs is a clinical-stage biotechnology company that is developing small-molecule kinase inhibitors as a targeted therapy for cancer. We are focused on treating Breast Cancer. Our patented cancer compounds position us in the lead to fast-track our product to market as it fills an unmet medical need. Our cancer therapy has the potential to save lives and improve quality of life.